Another study revealed that NSCLC patients with late-stage disease (stage II, III, and IV) show increased levels of TAM-derived IL-10 which is accompanied by lymph node metastases, pleural invasion, and lympho-vascular invasion (Figure 3; Wang et al., 2011). This evidence concerns the gene IL10 and non-small cell lung carcinoma.